Cancel anytime
Nu Skin Enterprises Inc (NUS)
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
12/11/2024: NUS (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Analysis of Past Performance
Type: Stock | Upturn Star Rating | Today’s Advisory: Consider higher Upturn Star rating |
Historic Profit: -26.71% | Upturn Advisory Performance 2 | Avg. Invested days: 23 |
Profits based on simulation | Stock Returns Performance 1 | Last Close 12/11/2024 |
Type: Stock | Today’s Advisory: Consider higher Upturn Star rating |
Historic Profit: -26.71% | Avg. Invested days: 23 |
Upturn Star Rating | Stock Returns Performance 1 |
Profits based on simulation Last Close 12/11/2024 | Upturn Advisory Performance 2 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 331.08M USD |
Price to earnings Ratio - | 1Y Target Price 6.92 |
Dividends yield (FY) 3.64% | Basic EPS (TTM) -2.09 |
Volume (30-day avg) 807496 | Beta 1.13 |
52 Weeks Range 5.90 - 20.26 | Updated Date 12/25/2024 |
Company Size Small-Cap Stock | Market Capitalization 331.08M USD | Price to earnings Ratio - | 1Y Target Price 6.92 |
Dividends yield (FY) 3.64% | Basic EPS (TTM) -2.09 | Volume (30-day avg) 807496 | Beta 1.13 |
52 Weeks Range 5.90 - 20.26 | Updated Date 12/25/2024 |
Earnings Date
Report Date - | When - |
Estimate - | Actual - |
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -5.81% | Operating Margin (TTM) 4.24% |
Management Effectiveness
Return on Assets (TTM) 5.55% | Return on Equity (TTM) -13.5% |
Revenue by Products
Revenue by Products - Current and Previous Year
Revenue by Geography
Revenue by Geography - Current and Previous Year
Valuation
Trailing PE - | Forward PE - |
Enterprise Value 598548164 | Price to Sales(TTM) 0.19 |
Enterprise Value to Revenue 0.34 | Enterprise Value to EBITDA 76.18 |
Shares Outstanding 49711000 | Shares Floating 48667586 |
Percent Insiders 2.29 | Percent Institutions 81.02 |
Trailing PE - | Forward PE - | Enterprise Value 598548164 | Price to Sales(TTM) 0.19 |
Enterprise Value to Revenue 0.34 | Enterprise Value to EBITDA 76.18 | Shares Outstanding 49711000 | Shares Floating 48667586 |
Percent Insiders 2.29 | Percent Institutions 81.02 |
Analyst Ratings
Rating 3 | Target Price 27.75 | Buy - |
Strong Buy - | Hold 3 | Sell - |
Strong Sell - |
Rating 3 | Target Price 27.75 | Buy - | Strong Buy - |
Hold 3 | Sell - | Strong Sell - |
AI Summarization
Nu Skin Enterprises Inc.: A Comprehensive Overview
Company Profile
History & Background: Nu Skin Enterprises Inc. (NYSE: NUS) is a global direct selling company founded in 1984 and headquartered in Provo, Utah. It develops and distributes personal care products, nutritional supplements, and technology solutions. Nu Skin operates in over 50 markets worldwide and has a diversified product portfolio catering to various consumer segments.
Core Business Areas:
- Personal Care: Nu Skin offers skincare, haircare, body care, and anti-aging products under its flagship Nu Skin brand and other sub-brands like ageLOC and Nutricentials.
- Nutritional Supplements: The company provides a range of nutritional products, including vitamins, minerals, protein powders, and weight management solutions.
- Technology Solutions: Nu Skin's technology division develops and markets innovative devices like the ageLOC LumiSpa and the Galvanic Spa System, which enhance the efficacy of its personal care products.
Leadership & Structure: The company is led by CEO Ryan Napierski and President Ritch Wood. Nu Skin follows a decentralized organizational structure with regional presidents overseeing operations in various markets.
Top Products and Market Share
Top Products: Nu Skin's top products include the ageLOC LumiSpa skin cleansing and treatment device, the Nutricentials personalized skincare line, and Pharmanex nutritional supplements like Marine Omega and LifePak.
Market Share: Nu Skin holds a significant market share in the global anti-aging skincare market, estimated at around 5%. In the US market, the company's market share is estimated to be around 2%.
Competitor Comparison: Nu Skin competes with other direct selling companies like Amway, Herbalife, and Mary Kay, as well as traditional beauty and supplement brands like L'Oreal, Unilever, and GNC. Nu Skin differentiates itself through its innovative product offerings, personalized approach, and focus on scientific research.
Total Addressable Market (TAM)
The TAM for Nu Skin is estimated to be vast. The global personal care market is valued at over $500 billion, while the global nutritional supplements market is estimated to be worth over $150 billion. Nu Skin only captures a small portion of these markets, highlighting significant potential for future growth.
Financial Performance
Recent Financials: Nu Skin's recent financials show a mixed picture. The company reported revenue of $2.2 billion for the fiscal year 2022, a slight decrease compared to the previous year. Net income was $182.4 million, with an EPS of $2.41. Profit margins have been under pressure due to rising input costs and increased competition.
Financial Health: Nu Skin maintains a healthy balance sheet with a strong cash position and manageable debt levels. However, the company's cash flow has declined in recent years, which is a point of concern.
Dividends and Shareholder Returns
Dividend History: Nu Skin has a consistent history of paying dividends. The current annual dividend yield is around 2.5%. The payout ratio is moderate, allowing room for future dividend increases.
Shareholder Returns: Nu Skin's stock price has been relatively volatile in recent years. Over the past five years, the total shareholder return is around 15%.
Growth Trajectory
Historical Growth: Nu Skin's historical growth has been moderate. The company has experienced periods of strong growth in emerging markets, but growth in mature markets has been slower.
Future Growth: Future growth will likely be driven by product innovation, expansion into new markets, and leveraging technology to enhance the customer experience. The company's recent focus on personalized skincare solutions and digital tools could provide significant growth opportunities.
Market Dynamics
Industry Trends: The personal care and nutritional supplements industries are characterized by increasing consumer demand for natural, personalized, and science-backed products. Additionally, the growing trend of online shopping is creating new opportunities for direct selling companies like Nu Skin.
Company Positioning: Nu Skin is well-positioned within the industry thanks to its strong brand recognition, innovative products, and robust global distribution network. The company's focus on digitalization and personalization could further strengthen its competitive position in the future.
Competitors
- Amway (AMWAY): A leading direct selling company with a similar product portfolio.
- Herbalife (HLF): A global nutrition company with a strong focus on weight management solutions.
- Mary Kay (MK): A direct selling company specializing in skincare and cosmetics.
- L'Oreal (OR): A global cosmetics and beauty giant with a vast product range.
- Unilever (UL): A multinational consumer goods company with a diverse portfolio, including personal care products.
- GNC (GNC): A leading retailer of nutritional supplements.
Competitive Advantages: Nu Skin's competitive advantages include its strong brand reputation, innovative product offerings, personalized approach, and global presence.
Competitive Disadvantages: The company faces challenges from larger competitors with more extensive distribution networks and marketing budgets. Additionally, Nu Skin is susceptible to regulatory scrutiny and negative perceptions associated with the direct selling industry.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Nu Skin Enterprises Inc
Exchange | NYSE | Headquaters | Provo, UT, United States |
IPO Launch date | 1996-11-21 | President, CEO & Director | Mr. Ryan S. Napierski |
Sector | Consumer Defensive | Website | https://www.nuskin.com |
Industry | Household & Personal Products | Full time employees | 3700 |
Headquaters | Provo, UT, United States | ||
President, CEO & Director | Mr. Ryan S. Napierski | ||
Website | https://www.nuskin.com | ||
Website | https://www.nuskin.com | ||
Full time employees | 3700 |
Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products. The company also provides wellness products, such as LifePak nutritional supplements, ageLOC TR90 weight management system, and Beauty Focus Collagen+. In addition, it is involved in the research and product development of skin care products and nutritional supplements. The company sells its products under the Nu Skin, Pharmanex, and ageLOC brands through retail stores, website, digital platforms, and independent direct sellers and marketers, as well as a service center. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.